Stock STOK STOKE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Stoke Therapeutics, Inc.

Equities

STOK

US86150R1077

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-24 EDT 		5-day change 1st Jan Change
14.41 USD -2.04% Intraday chart for Stoke Therapeutics, Inc. +3.67% +173.95%
05-22 Stoke Therapeutics Insider Sold Shares Worth $653,529, According to a Recent SEC Filing MT
05-07 Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
STOKE THERAPEUTICS, INC. Stock Stoke Therapeutics, Inc.
 751M -
MODERNA, INC. Stock Moderna, Inc.
 63.85B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.83B
LONZA GROUP AG Stock Lonza Group AG
 40.65B
CELLTRION, INC. Stock Celltrion, Inc.
 27.12B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.52B
  1. Stock Market
  2. Equities
  3. STOK Stock
  4. Charts Stoke Therapeutics, Inc.
  5. Sector Chart